Loss of muscle mass, also known as sarcopenia, is common among people with Cushing’s syndrome in long-term remission, and…
Forest Ray PhD
Forest Ray received his PhD in systems biology from Columbia University, where he developed tools to match drug side effects to other diseases. He has since worked as a journalist and science writer, covering topics from rare diseases to the intersection between environmental science and social justice. He currently lives in Long Beach, California.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Forest Ray PhD
A young woman with psychosis stemming from Cushing’s disease made a complete recovery through a combination of brain surgery…
Some 25% of Cushing’s disease patients — or 1 in every 4 — will develop Nelson’s syndrome (NS) after surgery…
A woman with a rare case of Cushing’s disease, in which rising cortisol triggered the production of yet more…
Cortisol fluctuations in a woman with Cushing’s disease were controlled successfully with Signifor (pasireotide LAR), possibly for the first…
Recorlev (levoketoconazole), Strongbridge Biopharma’s oral investigational therapy for endogenous Cushing’s syndrome, led to sustained improvements in cortisol…
Although mortality rates associated with endogenous Cushing’s syndrome have dropped in recent years, the disease is still linked to…
The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected…
Magnetic resonance imaging (MRI) is a better way to find pituitary tumors in Cushing’s disease than inferior petrosal sinus sampling…
Patients with ectopic Cushing’s syndrome face challenges in their healthcare management if they live in developing countries, according…